Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D. Vt.: No preliminary injunction in PhRMA suit against Vermont’s 340B drug law
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D.D.C.: Physician’s judicial challenge to CMS revocation of Medicare billing privileges was premature
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONDITIONS OF PARTICIPATION—PRRB DECISIONS: Merger-based SCH status starts when contractor receives complete application
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FALSE CLAIMS ACT—SETTLEMENT AGREEMENTS: Signal Diagnostics to pay $20.5M over alleged failure to return HRSA overpayments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE REFORM NEWS—Price transparency rule aims to give consumers clearer health care costs
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HOME HEALTH—DAB DECISIONS: Persistent oversight failures cost home health agency its Medicare agreement
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Classification of the hyperoxia monitoring device adjunct to pulse oximetry
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • QUALITY OF CARE—NOTICES: AHRQ delists patient safety organization for cause
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • STRATEGIC PERSPECTIVES: Lawsuits threaten CMS rule prohibiting Medicaid funding for youth gender-affirming care
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, FALSE CLAIMS ACT—SETTLEMENT AGREEMENTS: Signal Diagnostics to pay $20.5M over alleged failure to return HRSA overpayments, (Oct 6, 2026)

    Organizations Mentioned:Signal Diagnostics LLC

    By Patricia K. Ruiz, J.D.

    The settlement resolves allegations laboratory retained funds tied to COVID-19 testing claims for insured patients.

    Signal Diagnostics LLC has agreed to pay more than $20.5 million to resolve allegations that it violated the False Claims Act (FCA) by ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use